TREM1 and obesity due to melanocortin 4 receptor deficiency: TREM1 has also been shown to be associated with obesity, diabetes (Subramanian et al., 2017), cardiovascular disease (Kouassi et al., 2018), cancer (Raggi & Bosco, 2020), and incident dementia (Walker et al., 2021).